CCB/ACE inhibitor dual therapy for hypertension lowers cardiovascular risk.
作者信息
Mitka Mike
出版信息
JAMA. 2008 May 21;299(19):2263-4. doi: 10.1001/jama.299.19.2263.
PMID:18492960
Abstract
摘要
相似文献
1
CCB/ACE inhibitor dual therapy for hypertension lowers cardiovascular risk.
JAMA. 2008 May 21;299(19):2263-4. doi: 10.1001/jama.299.19.2263.
2
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2068-9; author reply 2069-70. doi: 10.1001/jama.289.16.2068-c.
3
From Tritace to Tri-Plen - the South African journey.
Cardiovasc J Afr. 2009 Jan-Feb;20(1):69-70.
4
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2067-8; author reply 2069-70. doi: 10.1001/jama.289.16.2067.
5
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2066; author reply 2069-70. doi: 10.1001/jama.289.16.2066-a.
6
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2068; author reply 2069-70. doi: 10.1001/jama.289.16.2068-b.
7
Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
JAMA. 2004 Dec 15;292(23):2849-59. doi: 10.1001/jama.292.23.2849.
8
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2066-7; author reply 2069-70. doi: 10.1001/jama.289.16.2066-c.
9
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA. 2003;289(16):2068; author reply 2069-70. doi: 10.1001/jama.289.16.2068-a.
10
Does it matter how hypertension is controlled?
N Engl J Med. 2008 Dec 4;359(23):2485-8. doi: 10.1056/NEJMe0808690.
Zotero 插件